Marijuana stocks don't get much cheaper than this.
One highly popular pot stock just effectively halved its projected output for the upcoming year.
These companies don't possess the qualities Buffett would typically look for in an investment.
The most popular cannabis stocks on the planet just proved that the grass isn't getting greener -- at least not yet.
Once blazing hot, the appetite for cannabis mergers and acquisitions has cooled considerably in the United States.
Seeking out specific types of investments could have your portfolio thriving when the next recession strikes.
Will your state be "going green" next year?
It could take years for the Food and Drug Administration to produce a regulatory framework for CBD.
Don't let fear or misinformation lead you to a hasty decision.
More than 2,000 people in the U.S. have been hit with mysterious lung illnesses tied to vaping in recent months.
The inevitable just got pushed back by up to six months.
This hasn't happened since 1982.
Profits from Canadian pot stocks may come with an asterisk.
Here are five less-than-obvious reasons Cronos Group's operating results are a major disappointment.
A bipartisan approach would make America's most important social program a lot stronger.
Yet another marijuana stock cautions that its upcoming earnings release won't be up to par.
Short-sellers piled into these cannabis stocks between mid-September and mid-October.
Forget the yield-curve inversion. This is a more telltale sign that trouble is brewing.
Cannabis stocks are down, but they're probably not out.
The largest pot stock in the world is set to release its fiscal second-quarter operating results tomorrow, before the opening bell.